semaglutide gut health and constipation explained Highland - GLP-1s get all

Other risk factors that may increase vulnerability include: Long duration of diabetes (typically more than 10 years) Poor glycaemic control prior to starting GLP-1 therapy (HbA1c significantly above target) Rapid reduction in HbA1c (a drop of more than 2 percentage points [22 mmol/mol] within 36 months) Concurrent hypertension , especially if poorly controlled Diabetic kidney disease (nephropathy), which often correlates with retinopathy severity Previous history of retinal treatment (laser photocoagulation or intravitreal injections) People with type 2 diabetes but no retinopathy appear to have minimal risk of retinopathy progression based on current evidence

compounded medications are not FDA-approved like brand products but are manufactured under strict pharmaceutical standards

W., Riediger, T., Lutz, T

This year, one medication continues to dominate headlines, clinic discussions, and social media buzz: Semaglutide

\Circadian Rhythm Support: May help normalize disrupted sleep-wake cycles

join 15,000+ who have chosen us Your path to wellness, simplified